Uncommon presentation of gastrointestinal tuberculosis-A case series.

Uncommon presentation of gastrointestinal tuberculosis-A case series.

Publication date: Jan 01, 2025

Tuberculosis (TB) is a common disease in underdeveloped countries. Of all tuberculosis cases worldwide, 28% were reported from India. The most prevalent site of infection is the lungs (pulmonary TB), whereas extrapulmonary tuberculosis (EPTB) is less common. The most common form of EPTB in India is Lymph Node TB, which accounts for around 35% of total EPTB cases. Splenic tuberculosis incidence is 8 % whereas tuberculosis of pancreas and gall bladder is extremely rare. Pancreatic and gallbladder tuberculosis (GT) is extremely rare and presents with non-specific features. The clinical manifestations of EPTB are variable, imitate other diseases, and are usually confused with other diseases. Thus, it is crucial to be cautious and highly suspicious of EPTB infection in endemic areas. Probability of developing EPTB in immunocompromised patients is higher than in immunocompetent patients. The burden of EPTB in HIV patients ranges from 15 to 20% of all TB cases in HIV-negative patients, while in HIV-positive people, it accounts for around 40-50% of new TB cases. Histopathological examination (HPE) and positive Acid-Fast Bacilli (AFB) smears are used to make the diagnosis. ATT is given to such patients for 6 months. Due to such a diverse presentation of TB, here, we report a case series of extrapulmonary TB occurring in the abdomen in, pancreas, gallbladder, and spleen.

Concepts Keywords
Afb Acid-fast bacilli (AFB)
Fast Adult
Gallbladder Antitubercular Agents
Immunocompetent Antitubercular Agents
Tuberculosis CBNAAT
Extrapulmonary tuberculosis (EPTB)
Female
Gallbladder Diseases
Gallbladder TB
Gastrointestinal tract TB
Humans
India
Male
Middle Aged
Pancreatic Diseases
Pancreatic TB
Splenic TB
Tuberculosis, Gastrointestinal
Tuberculosis, Splenic

Semantics

Type Source Name
disease MESH gastrointestinal tuberculosis
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease IDO site of infection
disease MESH extrapulmonary tuberculosis
disease MESH Splenic tuberculosis
disease MESH infection
disease MESH immunocompromised patients
drug DRUGBANK 5-amino-1 3 4-thiadiazole-2-thiol
disease MESH Gallbladder Diseases
disease MESH Pancreatic Diseases

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *